Aim of the present study was to prepare and evaluate extended-release matrix tablets of Glibenclamide using hydrophilic polymer Polyvinyl pyrrollidone alone or in combination with hydrophobic polymer ethyl cellulose. Release kinetics was evaluated by using United States Pharmacopeia (USP)-22 type I dissolution apparatus. The higher rate and extent of Glibenclamide (GLB) released from Tablet prepared by dissolving method (TDM) solid dispersion tablets is due to hydrostatic interaction of PVP. With the release of surface drug, numerous pores and channels are generated through which dissolution media enters into the tablet and further elevates the rate and extant of GLB release rate. On the other hand, water soluble excipients such as lactose results in as increase in the drug release rate due to an increment in porosity (due to the dissolution of the drug). Moreover, presence of Ethyl cellullose played a meaningful role in controlling the drug release for 12 hours. Kinetics treatment revealed that dissolution efficiency up to 12 h is higher in TDM formulation. The kinetics showed that the release of drug followed Zero order kinetics. In conclusion, the results suggest that the developed extended-release tablets of Glibenclamide could perform therapeutically better than conventional dosage forms, leading to improve efficacy and better patient compliance.